Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Obesity01:24

Obesity

347
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
347
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

818
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
818
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

489
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
489
Imbalances in Cardiac Output01:23

Imbalances in Cardiac Output

1.2K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to...
1.2K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intravascular Imaging Versus Physiology Assessment for Intermediate Lesions During PCI.

Biomedicines·2026
Same author

Editorial for the Special Issue "Diabetes, Hypertension, and Cardiovascular Diseases: New Insights, Risk Factors, and Drug Therapies".

Medicina (Kaunas, Lithuania)·2026
Same author

Single Interventions (Pharmacological or Renal Denervation) Are Not Sufficient to Achieve Blood Pressure Control in Resistant Hypertension a Systematic Review and Meta-Analysis.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

Three-Year Durability of Radiofrequency Renal Denervation: SPYRAL HTN-ON MED.

Journal of the American Heart Association·2026
Same author

Contemporary Transcatheter Approaches to Mitral Regurgitation.

Reviews in cardiovascular medicine·2026
Same author

Left Atrioventricular Coupling Index: A Comprehensive Review of the Literature.

Life (Basel, Switzerland)·2026

Related Experiment Video

Updated: May 14, 2025

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

1.3K

Tracking Pathways Linking Obesity with Heart Failure.

Eleni Manta1, Panagiotis Iliakis1, Christos Fragoulis1

  • 1First Department of Cardiology, Hippokration General Hospital, Medical School, National and Kapodistrian University of Athens, 114 Vasilissis Sofias Avenue, 11527 Athens, Greece.

Nutrients
|April 12, 2025
PubMed
Summary

Obesity worsens heart failure by promoting inflammation and congestion. Treating obesity improves survival and cardiac function in heart failure patients.

Keywords:
GLP-1 receptor agonistsbariatric surgerycongestionheart failureinflammationobesityweight loss

More Related Videos

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
10:17

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

6.9K
A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
06:28

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

Published on: April 28, 2023

749

Related Experiment Videos

Last Updated: May 14, 2025

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

1.3K
An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
10:17

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

6.9K
A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
06:28

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

Published on: April 28, 2023

749

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Pathophysiology

Background:

  • Obesity is a significant risk factor for developing heart failure.
  • Obesity exacerbates existing heart failure through hormonal and inflammatory pathways.
  • Co-existing nutritional and muscular abnormalities like cachexia and sarcopenia are common in heart failure patients with obesity.

Purpose of the Study:

  • To review the complex relationship between obesity and heart failure.
  • To highlight the therapeutic effects of weight-loss interventions on cardiac function.

Main Methods:

  • Literature review focusing on obesity, heart failure, and weight-loss interventions.
  • Analysis of pathophysiological mechanisms linking obesity to heart failure.
  • Evaluation of therapeutic strategies including interventional, pharmaceutical, and dietary approaches.

Main Results:

  • Obesity contributes to heart failure development and progression via inflammation and congestion.
  • Weight-loss interventions show a positive impact on survival and cardiac function in heart failure patients.
  • Nutritional and muscular deficits often accompany obesity in heart failure, influencing treatment outcomes.

Conclusions:

  • Effective management of obesity is crucial for improving outcomes in heart failure patients.
  • Weight-loss programs offer a significant therapeutic benefit for cardiac function in this population.
  • Addressing co-morbidities like sarcopenia is essential for comprehensive patient care.